Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy

• Published in: Journal of diabetes investigation Vol. 12; no. 8; pp. 1322 - 1325
• Main Authors: Lin, Kuan‐Yu, Hsih, Wen‐Hui, Lin, Yen‐Bo, Wen, Chen‐Yu, Chang, Tien‐Jyun
• Format: Journal Article
• Language: English
• Published: Japan John Wiley & Sons, Inc 01.08.2021; John Wiley and Sons Inc; Wiley
• Subjects: Automation; Biomarkers; Blood pressure; Clinical medicine; Clinical trials; Diabetes; Diabetes mellitus; Diabetes Mellitus - epidemiology; Diabetes retinopathy; Diabetic retinopathy; Diabetic Retinopathy - diagnosis; Diabetic Retinopathy - epidemiology; Diabetic Retinopathy - therapy; Edema; Epidemiology; Humans; Hyperglycemia; Hypertension; JDI Updates; Lasers; Mass Screening; Neurodegeneration; Prevalence; Retinopathy; Risk Factors; Screening; Telemedicine; Treatment; Vascular endothelial growth factor; Vision; Visual impairment; Screening; Diabetes retinopathy; Treatment; Epidemiology; Risk factors
• ISSN: 2040-1116; 2040-1124; 2040-1124
• DOI: 10.1111/jdi.13480

Despite progress in the treatment of diabetic macular edema and diabetic retinopathy, the rate of lower fundus examination due to limitations of medical resources delays the diagnosis and treatment of diabetic retinopathy. Therefore, implementation of automated diabetic retinopathy screening program and the identification of more specific and sensitive biomarkers are important for facilitating the earlier detection of diabetic macular edema and diabetic retinopathy to decrease the prevalence of poor vision and blindness.